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Iatrogenic coronary dissection during coronary stenting
the LAD coronary artery was good before the 
intervention, but after the dissection despite good 
anastomosis with patch angioplasty, quality of 
the LAD coronary artery was not satisfactory. If 
this case had been operated before dissection, 
postoperative LAD quality would have been 
better. So, after this complication we began to 
think that the results of surgery would be better in 
severe ISR  treatment.
In conclusion, IS R  rem ains a challenging 
problem and optimal management is yet to be 
determined. Despite better percutenous coronary 
interventional resu lts, restenosis and 
complication risk are still high in most cases. In 
patients having ISR  with low potential success 
and high complication rate, C A B G  surgery 
seem s to yield the best outcome.
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ABSTRACT
With advancing age immobile amelanotic 
conjunctival lesions of the interpalpebral area 
may often be seen. Considering these lesions, 
we should think of papilloma, leukoplaki and also 
conjunctiva cancer. In this case  report we 
present an 80-year-old patient who was admitted 
to our clinic with the complaint of a m ass in her 
right eye.
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INTRODUCTION
Conjunctival squam ous cell cancer (C S C C ) 
characteristically occurs as an am elanotic, 
fleshy, often papillamotous m ass near the 
corneascleral limbus or, occasionally, in the 
forniceal or palpebral conjunctiva (1). It 
frequently displays white ceratin on its surface
(1 ) . In the conjunctiva, S C C  occurs about ten 
times more frequently than the basal- cell type
(2 ) . They usually arise at the limbus and spread 
to the cornea and adjacent bulbar conjunctiva. A 
limbal carcinoma sometimes invades the sclera 
and, very infrequently the cornea but usually 
Bowman’s membrane acts as a barrier to the 
corneal invasion (3,4). In extremely rare cases 
the tumor extends through the sclera into the 
intra ocular structures. Ophthalmic, especially
conjunctiva tumors are not often seen in clinics 
and their differential diagnosis is usually made by 
inspection. It is sometimes difficult to differentiate 
benignant lesions from malignant ones.
CASE REPORT
An 80-year -old woman w as admitted to the 
hospital with a progressively enlarging, painless 
fleshy lesion in her right eye. Her history was 
otherwise noncontributory. In the right eye, there 
was a lesion superotemporally arising from the 
limbal conjunctiva and invading the cornea 
(Fig. 1). Dilated conjunctiva blood vesse ls around 
the lesion were also observed.
F ig . 1 : Conjunctival fleshy lesion invading the cornea.
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The lesion w as removed by partial 
keratoconjunctivectomy, marking the conjunctiva 
border elevated from the limbal cornea with 
subconjunctival serum physiologic injection. 
Postoperatively, there was no limbal insufficiency 
due to surgery.
Microscopically, the tumor was confined to the 
epithelium, and the basement membrane was 
intact. Nonceratinized squam ous epithelia 
showed loss of its chromaticity and polarity, 
features of actinic keratozis, and underneath it 
had a layer of lymphocytic infiltration (Fig. 2, grey 
arrow). In the stroma, there was an island of 
(F ig .2, black arrow) intensive atypical molecular 
cell infiltration which belongs to C S C C . (Fig. 3)
F ig .2 : The lesion after excision.
F ig .3  : Nonkeratinised squamous cell epithelia, underneath this 
an island of CSCC.
DISCUSSION
The decision on how to manage conjunctiva 
lesions is based on assessm ent of relevant
history and the clinical features of the lesion. 
Information is limited on how well 
ophthalmologists process this information in 
order to make a correct diagnosis (5). The 
lesions which come to mind when faced with a 
conjunctiva lesion should include; papilloma, 
neoplastic papilloma, Bowen d isease and 
leukoplaki (6).
A papilloma may at times be confused with a 
S C C : in the transitional stage it may be difficult to 
determine, even on histological examination, 
whether it is a papilloma or early C S C C . But later 
on, the elevated appearance and the location 
(caruncular or forniceal not limbal) help in the 
differential diagnosis. Neoplastic papilloma which 
is often seen in older people, is usually one-sided 
and like bulbar conjunctiva and limbus. It may 
change to C S C C . Neoplastic papillomas may be 
misdiagnosed as C S C C  due to the limbal 
localization of both lesions, but pathologically 
abundant core vascular structures surrounded by 
atypical cells of neoplastic papillomas help in 
differential diagnosis. Bowen d isease  most 
commonly appears in the interpalpebral fissure, 
especially at the limbus. Clinically, these lesions 
may be covered by a white scale (keratin). The 
term leukoplaki literally means white plaque and 
conveys no information about the underlying 
problem which produced the excess keratin. In 
the differential diagnosis, reached by 
pathological examination, atypical cells present 
only in epithelia in carcinoma in situ and cells 
spread to the stroma passing basement 
membrane in C S C C .
Although a C S C C  may not show progression or 
métastasés over some years, surgery is often 
necessary. Cryotherapy, excision, intra lesional 
alpha-interferon injection or combined surgery 
with Mitomycin-C has been reported to be 
successful in treating these lesions (6). During 
surgery the malignant neoplasm of the conjunctiva 
should be removed by meticulous microsurgery, 
taking great care not to disrupt the tumor.
In conclusion, conjunctiva cancers are rarely seen 
in clinics. It is possible to excise these lesions like 
in our case . Adjunctive therapy such as 
cryotherapy or Mitomycin C should not be used as 
a first line of treatment (6). In the follow-up of our 
patient for the first 3 years, we did not see any 
recurrence.
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